SCHEMBL5472191

SCHEMBL5472191

CC(Cc1ccccn1)Nc1cc[c]cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 1/20 0.38
PDE10A Q9Y233 1/20 0.38
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2A Q12879 1/20 0.38
GRIN2B Q13224 1/20 0.38
GRIN2C Q14957 1/20 0.38
GRIN3A Q8TCU5 1/20 0.38
FDPS P14324 1/20 0.37
PTPRA P18433 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
POLB P06746 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777942 0.75 MAOA (0.53) ALDH1A1CYP1A2CYP2C19MAPTSMN1; SMN2
SCHEMBL4776298 0.72 CYP1A2 (0.69) ALDH1A1CYP1A2CYP2C19HRH3MAPT
SCHEMBL13188544 0.72 TAAR1 (0.52) ALDH1A1CYP1A2CYP2C19GRIN2DGRIN3B
SCHEMBL742490 0.71 HCAR3 (0.41) CYP1A2PDE10ASMN1; SMN2LMNAHTT
SCHEMBL2352782 0.71 GRIN2D (0.55) ALDH1A1CYP1A2CYP2C19GRIN2DGRIN3B
SCHEMBL5556929 0.71 CYP1A2 (0.51) CYP1A2GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL11524829 0.71 TAAR1 (0.53) ALDH1A1CYP1A2CYP2C19GRIN2DGRIN3B
SCHEMBL4794651 0.70 NUDT1 (0.48) ALDH1A1KDM4E
SCHEMBL5407261 0.70 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP2C19PDE10AGRIN2D
SCHEMBL1039370 0.68 PTPRA (0.59) ALDH1A1CYP1A2CYP2C19GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265256-A1 Phosphodiesterase 10 inhibitors AMGEN INC. 2007-11-15 US claimed
US-20070265256-A1 Phosphodiesterase 10 inhibitors AMGEN INC. 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265256-A1 Phosphodiesterase 10 inhibitors PDE7A, PDE7B, PDE10A ALDH1A1 365/4885CYP1A2 748/4885CYP2C19 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.